Insulin-like growth factor binding protein 1 (IGFBP-1) antibody and antigen (hapten, BSA/OVA conjugated)

Diagnostic anti-Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies (anti-Insulin-like growth factor binding protein 1, anti-IGFBP-1) and diagnostic hapten-carrier conjugates BSA-Insulin-like growth factor binding protein 1 (IGFBP-1), OVA-Insulin-like growth factor binding protein 1 (IGFBP-1), KLH-Insulin-like growth factor binding protein 1 (IGFBP-1) antigens for Hormone disorders IGFBP-1 detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Hormone disorders diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-SMT-IGFBP-1-Ag01 BSA-Insulin-like growth factor binding protein 1 (IGFBP-1) $756.00
GMP-SMT-IGFBP-1-Ag02 OVA-Insulin-like growth factor binding protein 1 (IGFBP-1) $756.00
GMP-SMT-IGFBP-1-Ab01 Anti-human Insulin-like growth factor binding protein 1 (IGFBP-1) mouse monoclonal antibody (mAb) $1953.00
GMP-SMT-IGFBP-1-Ab02 Anti-human Insulin-like growth factor binding protein 1 (IGFBP-1) human monoclonal antibody (mAb) $1953.00

Size: 1mg | 10mg | 100mg



Product Description

BSA-Insulin-like growth factor binding protein 1 (IGFBP-1)

Cat No. GMP-SMT-IGFBP-1-Ag01
Product Name BSA-Insulin-like growth factor binding protein 1 (IGFBP-1)
Target Insulin-like growth factor binding protein 1 (IGFBP-1)
Expression platform Synthetic
Bioactivity validation Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IGFBP-1 level test of Hormone disorders (Pregnancy) and related syndrome evaluation
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Insulin-like growth factor binding protein 1 (IGFBP-1) / OVA-Insulin-like growth factor binding protein 1 (IGFBP-1) is Synthetic.
Purity High (TBD)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

OVA-Insulin-like growth factor binding protein 1 (IGFBP-1)

Cat No. GMP-SMT-IGFBP-1-Ag02
Product Name OVA-Insulin-like growth factor binding protein 1 (IGFBP-1)
Target Insulin-like growth factor binding protein 1 (IGFBP-1)
Expression platform Synthetic
Bioactivity validation Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IGFBP-1 level test of Hormone disorders (Pregnancy) and related syndrome evaluation/td>
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Insulin-like growth factor binding protein 1 (IGFBP-1) / OVA-Insulin-like growth factor binding protein 1 (IGFBP-1) is Synthetic.
Purity High (TBD)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Insulin-like growth factor binding protein 1 (IGFBP-1) mouse monoclonal antibody (mAb)

Cat No. GMP-SMT-IGFBP-1-Ab01
Product Name Anti-human Insulin-like growth factor binding protein 1 (IGFBP-1) mouse monoclonal antibody (mAb)
Target Insulin-like growth factor binding protein 1 (IGFBP-1)
Expression platform hybridoma
Isotypes Mouse IgG
Bioactivity validation Insulin-like growth factor binding protein 1 (IGFBP-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies in IGFBP-1 level test of Hormone disorders (Pregnancy) and related syndrome evaluation.
Tag mFc
Products description Anti-human Insulin-like growth factor binding protein 1 (IGFBP-1) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
Purity High (TBD)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Insulin-like growth factor binding protein 1 (IGFBP-1) human monoclonal antibody (mAb)

Cat No. GMP-SMT-IGFBP-1-Ab02
Product Name Anti-human Insulin-like growth factor binding protein 1 (IGFBP-1) human monoclonal antibody (mAb)
Target Insulin-like growth factor binding protein 1 (IGFBP-1)
Expression platform hybridoma
Isotypes Human IgG1
Bioactivity validation Insulin-like growth factor binding protein 1 (IGFBP-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies in IGFBP-1 level test of Hormone disorders (Pregnancy) and related syndrome evaluation.
Tag hFc
Products description Anti-human Insulin-like growth factor binding protein 1 (IGFBP-1) mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS, PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Premature rupture of membranes (PROM) is essential to maintain the pregnancy. Various diagnosis method has been used to diagnose PROM. Insulin-like growth factor binding protein-1 (IGFBP-1) is present in an essentially higher concentration in amniotic fluid, than in serum, cervical mucous, urine and seminal plasma. IGFBP is present in high concentration in amniotic fluid.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.